a:3:{s:6:"_token";s:40:"uB6r7H7ioLl8LfuQOvBP0GvPZ7yB5E1Ae7SBXhki";s:9:"_previous";a:1:{s:3:"url";s:167:"https://www.pharmafocusasia.com/news/nurix-therapeutics-granted-fast-track-designation-by-the-us-fda-for-nx-5948-in-the-treatment-of-relapsed-or-refractory-cll-and-sll";}s:6:"_flash";a:2:{s:3:"old";a:0:{}s:3:"new";a:0:{}}}